Literature DB >> 1378881

Expression of the major core antigen VP7 of African horsesickness virus by a recombinant baculovirus and its use as a group-specific diagnostic reagent.

T Chuma1, H Le Blois, J M Sánchez-Vizcaíno, M Diaz-Laviada, P Roy.   

Abstract

The major core protein, VP7, of African horsesickness virus serotype 4 (AHSV-4), the aetiological agent of a recent outbreak of the disease in southern Europe, was expressed in insect cells infected with a recombinant baculovirus containing a cloned copy of the relevant AHSV gene (S7). Analyses of its biochemical and antigenic properties confirmed the authenticity of the protein expressed. The high-level expression of VP7 under the control of the strong polyhedrin promoter of Autographa californica nuclear polyhedrosis virus induced disc-shaped crystals in infected insect cells. This enabled us to purify the protein by a one-step ultracentrifugation procedure and to utilize it for the detection of antibodies raised in horses to various serotypes of AHSV. A serological relationship between AHSV and two other orbiviruses, bluetongue virus and epizootic haemorrhagic disease virus, was also demonstrated.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1378881     DOI: 10.1099/0022-1317-73-4-925

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  11 in total

1.  Serologic markers in early stages of African horse sickness virus infection.

Authors:  J L Martínez-Torrecuadrada; M Díaz-Laviada; P Roy; C Sánchez; C Vela; J M Sánchez-Vizcaíno; J I Casal
Journal:  J Clin Microbiol       Date:  1997-02       Impact factor: 5.948

2.  RGD tripeptide of bluetongue virus VP7 protein is responsible for core attachment to Culicoides cells.

Authors:  B H Tan; E Nason; N Staeuber; W Jiang; K Monastryrskaya; P Roy
Journal:  J Virol       Date:  2001-04       Impact factor: 5.103

3.  An indirect double-antibody sandwich enzyme-linked immunosorbent assay (ELISA) using baculovirus-expressed antigen for the detection of antibodies to glycoprotein E of pseudorabies virus and comparison of the method with blocking ELISAs.

Authors:  T G Kimman; O de Leeuw; G Kochan; B Szewczyk; E van Rooij; L Jacobs; J A Kramps; B Peeters
Journal:  Clin Diagn Lab Immunol       Date:  1996-03

4.  Crystal structure of the top domain of African horse sickness virus VP7: comparisons with bluetongue virus VP7.

Authors:  A K Basak; P Gouet; J Grimes; P Roy; D Stuart
Journal:  J Virol       Date:  1996-06       Impact factor: 5.103

5.  Vaccinia virus expression of the VP7 protein of South African bluetongue virus serotype 4 and its use as an antigen in a capture ELISA.

Authors:  M Cloete; D H du Plessis; A A van Dijk; H Huismans; G J Viljoen
Journal:  Arch Virol       Date:  1994       Impact factor: 2.574

6.  Oncolytic bluetongue viruses: promise, progress, and perspectives.

Authors:  Joseph K-K Li
Journal:  Front Microbiol       Date:  2011-03-16       Impact factor: 5.640

7.  Immunogenicity of plant-produced African horse sickness virus-like particles: implications for a novel vaccine.

Authors:  Susan J Dennis; Ann E Meyers; Alan J Guthrie; Inga I Hitzeroth; Edward P Rybicki
Journal:  Plant Biotechnol J       Date:  2017-08-01       Impact factor: 9.803

8.  Development of a Novel Reverse Transcription Loop-Mediated Isothermal Amplification Assay for the Rapid Detection of African Horse Sickness Virus.

Authors:  V L Fowler; E L A Howson; J Flannery; M Romito; A Lubisi; M Agüero; P Mertens; C A Batten; H R Warren; J Castillo-Olivares
Journal:  Transbound Emerg Dis       Date:  2016-08-02       Impact factor: 5.005

Review 9.  African Horse Sickness: A Review of Current Understanding and Vaccine Development.

Authors:  Susan J Dennis; Ann E Meyers; Inga I Hitzeroth; Edward P Rybicki
Journal:  Viruses       Date:  2019-09-11       Impact factor: 5.048

10.  Serotype- and serogroup-specific detection of African horsesickness virus using phage displayed chicken scFvs for indirect double antibody sandwich ELISAs.

Authors:  Wouter van Wyngaardt; Cordelia Mashau; Isabel Wright; Jeanni Fehrsen
Journal:  J Vet Sci       Date:  2013-02-05       Impact factor: 1.672

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.